Biochemical effects of the mouse hepatocarcinogen oxazepam: Similarities to phenobarbital

Fundamental and Applied Toxicology

Volumn 29, Issue 1, 1996, Pages 147-154

  Griffin, Robert J ^a   Dudley, Chris N ^a   Cunningham, Michael L ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; GLUTATHIONE; OXAZEPAM; PHENOBARBITAL; THYROTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INDUCTION; LIVER CARCINOGENESIS; LIVER CELL; MALE; MOUSE; NONHUMAN;

ANIMALIA;

EID: 85033066793     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1996.0016     Document Type: Article

References (39)

1. Ahotupa, M., Bereziat, J.-C., Mantyla, E., and Bartsch, H. (1993). Dietary fat- and phenobarbital-induced alterations in hepatic antioxidant functions in mice. Carcinogenesis 14, 1225-1228.
2. Batzinger, R. P., Ou, S-Y. L., and Bueding, E. (1978). Antimutagenic effects of 2(3)-tert-butyl-4-hydroxyanisole and of antimicrobial agents. Cancer Res. 38, 4478-4485.
3. Bucher, J. R., Shackleford, C. C., Haseman, J. K., Johnson, J. D., Kurtz, P. J., and Persing, R. L. (1994). Carcinogenicity studies of oxazepam in mice. Fundam. Appl. Toxicol. 23, 280-297.
4. Clemmesen, J., and Hjalgrim-Jensen, S. (1978). Is phenobarbital carcinogenic? A follow-up of 8076 epileptics. Ecotoxicol. Environ. Saf. 1, 457-470.
5. Clemmesen, J., and Hjalgrim-Jensen, S. (1980). Epidemiological studies of medically used drugs. Arch. Toxicol. Suppl. 3, 19-25.
6. Cohen, G., Dembiec, D., and Marcus, J. (1970). Measurement of catalase activity in tissue extracts. Anal. Biochem. 34, 30-38.
7. Cunningham, M. L., Maronpot, R. R., Thompson, M., and Bucher, J. R. (1994). Early responses of the liver of B6C3F1 mice to the hepatocarcinogen oxazepam. Toxicol. Appl. Pharmacol. 124, 31-38.
8. Devereux, T. R., White, C. M., Sills, R. C., Bucher, J. R., Maronpot, R. R., and Anderson, M. W. (1994). Low frequency of H-ras mutations in hepatocellular adenomas and carcinomas and in hepatoblastomas from B6C3F1 mice exposed to oxazepam in the diet. Carcinogenesis 15, 1083-1087.
9. Diwan, B. A., Rice, J. M., and Ward, J. M. (1986). Tumor-promoting activity of benzodiazepine tranquilizers, diazepam and oxazepam, in mouse liver. Carcinogenesis 7, 789-794.
10. Fox, T. R., Schumann, A. M., Watanabe, P. G., Yano, B. L., Maher, V. M., and McCormick, J. J. (1990). Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens. Cancer Res. 50, 4014-4019.
11. Furakawa, K., Numoto, S., Furuya, K., Furukawa, N. T., and Williams, G. M. (1985). Effects of the hepatocarcinogen nafenopen, a peroxisomal proliferator, on the activities of rat liver glutathione requiring enzymes and catalase in comparison to the action of phenobarbital. Cancer Res. 45, 5011-5019.
12. Griffin, R. J., and Burka, L. T. (1993). The metabolism and elimination of oxazepam in mice. Drug Metab. Dispos. 21, 918-926.
13. Griffin, R. J., Burka, L. T., and Cunningham, M. L. (1995). Induction of hepatic drug metabolizing enzymes by prechronic oxazepam-dosed feed treatment in B6C3F1 mice. Toxicol. Lett. 76, 251-256.
14. Harvey, S. C. (1985). Hypnotics and sedatives. In The Pharmacological Basis of Therapeutics (A. G. Gilman, L. S. Goodman, T. W. Rail, and F. Mund, Eds.), pp 339-371. MacMillan, New York.
15. He, J-S., and Fulco, A. J. (1991). A barbiturate-regulated protein binding to a common sequence in the cytochrome P450 genes of rodents and bacteria. J. Biol. Chem. 266, 7864-7869.
16. Jones, C. R., and Lubet, R. A. (1992). Induction of a pleiotropic response by phenobarbital and related compounds. Biochem. Pharmacol. 44, 1651-1660.
17. Junqueira, V. B. C., Simizu, K., Pimentel, R., Azzalis, L. A., Barros, S. B. M., Koch, O., and Videla, L. A. (1991). Effect of phenobarbital and 3-methylcholanthreneon the early oxidative stress component induced by lindane in rat liver. Xenobiotica 21, 1053-1065.
18. Laird, H. E., II, Gemsh, K. E., Duerson, K. C., Putnam, C. W., and Russell, D. H. (1989). Peripheral benzodiazepine binding sites in Nb 2 node lymphoma cells: Effects on prolactin-stimulated proliferation and ornithine decarboxylase activity. Eur. J. Pharmacol. 171, 25-35.
19. Langner, J. G., Gan, B. K., Liu, R. H., Baugh, L. D., Chand, P., Weng, J-L., Edwards, C., and Walia, A. S. (1991). Enzymatic digestion, solid-phase extraction, and gas chromatography/mass spectrometry of derivatized intact oxazepam in urine. Clin. Chem. 37, 1595-1601.
20. Ledda-Columbano, G. M., Columbano, A., Curto, M., Ennas, M. G., Coni, P., Sarma, D. S. R., and Pani, P. (1989). Further evidence that mitogen-induced cell proliferation does not support the formation of enzyme altered islands in rat liver by carcinogens. Carcinogenesis 10, 847-850.
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
22. McClain, R. M. (1989). The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia. Toxicol. Pathol. 17, 294-306.
23. McClain, R. M., Levin, A. A., Posch, R., and Downing, J. C. (1989). The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol. Appl Pharmacol. 99, 216-228.
24. National Toxicology Program (NTP) Technical Report Series No. 443. (1993). Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice, NIH Publication No. 92-3359. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.
25. Noguchi, T., Cantor, A., and Scott, M. (1973). Mode of action of selenium and vitamin E in prevention of exudative diathesis in chicks. J. Nutr. 104, 1502-1511.
26. Olsen, J. H., Wallin, H., Boice, J. D., Rask, K., Schulgen, G., and Fraumeni, J. F. (1993). Phenobarbital, drug metabolism, and human cancer. Cancer Epidemiol. Prevent. 2, 449-452.
27. Omura, T., and Sato, R. (1964). The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239, 2370-2378.
28. Ray, J. S., Harbison, M. L., McClain, R. M., and Goodman, J. I. (1994). Alterations in the methylation status and expression of the ras oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors. Mol. Carcinog. 9, 155-166.
29. Rice, J. M., Diwan, B. A., Hu, H., Ward, J. M., Nims, R. W., and Lubet, R. A. (1994). Enhancement of hepatocarcinogenesis and induction of specific cytochrome P450 dependent monooxygenase activities by the barbiturates allobarbital, aprobarbital, pentobarbital, secobarbital and 5-phenyl- and 5-ethylbarbituric acids. Carcinogenesis 15, 395-402.
30. Sasaki, K-I., Furusawa, S., Monma, K., and Takayanagi, G. (1983). Potentiation of the antitumor activity of tegafur in sarcoma 180-bearing mice by chlordiazepoxide, diazepam and oxazepam. Chem. Pharm. Bull. 31, 2451-2458.
31. Slater, T. F., and Sawyer, B. C. (1971). The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. Biochem. J. 123, 805-818.
32. Smith, P.P., O'Bnan, K.A., and Keenan, K.P. (1991). Evaluation of bromodeoxyuridine labeling in hepatomegaly produced by peroxisomal proliferation or P-450 induction in rodents. In Chemically Induced Cell Proliferation: Implications for Risk Assessment (B.E. Butterworth, T.J. Slaga, W. Farland, and M. McClam, Eds.), pp. 285-289. Wiley-Liss, New York.
33. Standeven, A. M., and Wetterhahn, K. E. (1991). Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation. Toxicol. Appl. Pharmacol. 107, 269-284.
34. Stopper, H., Korber, C., Spencer, D. L., Kirchner, S., Caspary, W. J., and Schiffman, D. (1993). An investigation of micronucleus and mutation induction by oxazepam in mammalian cells. Mutagenesis 8, 449-455.
35. Swenberg, J. A., Dietrich, D. R., McClain, R. M., and Cohen, S. M. (1992). Species-specific mechanisms of carcinogenesis. In Mechanisms of Carcinogenesis in Risk Identification (H. Varnio, P. N. Magee, D. B. McGregor, and A. J. McMichael, Eds.), pp. 477-500. IARC, Lyon.
36. Sun, M., and Zigman, S. (1978). An improved spectrophotometric assay for superoxide dismutase based on epinephrine autooxidation. Anal. Biochem. 90, 81-89.
37. Temple, A. R., Done, A. K., and Clement, M. S. (1971). Studies of glucuronidation. III. The measurement of p-nitrophenyl glucuronide. J. Lab. Clin. Med, 77, 1015-1019.
38. Upadhya, P., Rao, M. V., Venkateswar, V., Rangarajan, P. N., and Padmanaban, G. (1992). Identification and functional characterization of a cis-acting positive DNA element regulating CYP2B1/2B2 gene transcription in rat liver. Nucleic Acids Res. 20, 557-562.
39. Van Raaij, J. A. G. M., Kaptein, E., Visser, T. J., and Van Den Berg, K. J. (1993). Increased glucuronidation of thyroid hormone in hexachlorobenzene-treated rats. Biochem. Pharmacol. 43, 627-631.